PetIQ

General Information
Business:

PetIQ is a rapidly growing distributor and manufacturer of veterinarian-grade pet Rx medications, OTC flea and tick preventatives and health and wellness products for dogs and cats. We pioneered and are the leading seller to the retail channel of pet products that were previously available for purchase primarily from veterinary clinics. We enable our customers to offer pet owners choice, affordability and convenience on products from leading national brands as well as our proprietary value-branded alternatives.

Industry: DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES
Employees: 202
Founded: 2016
Contact Information
Address 500 E. Shore Dr., Suite 120, Eagle, ID 83616, US
Phone Number 208-939-8900
Web Address http://www.petiq.com
View Prospectus: PetIQ
Financial Information
Market Cap $331.0mil
Revenues $214.9 mil (last 12 months)
Net Income $1.2 mil (last 12 months)
IPO Profile
Symbol PETQ
Exchange NASDAQ
Shares (millions): 6.3
Price range $16.00 - $16.00
Est. $ Volume $100.0 mil
Manager / Joint Managers Jefferies/ William Blair
CO-Managers Oppenheimer/ Raymond James/ SunTrust Robinson Humphrey
Expected To Trade: 7/21/2017
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change